Exhibit 10.16

 

AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT

 

This AMENDED AND RESTATED EXCLUSIVE LICENSING AGREEMENT (“Agreement”) is entered
into effective as of February 5, 2003, between Natural Alternatives
International, Inc., a Delaware corporation (“NAI”), with its principal offices
at 1185 Linda Vista Drive, San Marcos, California 92069, and the Chopra
Enterprises, LLC, a California limited liability company (“Chopra Enterprises”),
Deepak Chopra, M.D., an individual (“Deepak Chopra”) and David Simon, M.D., an
individual (“Simon”). Chopra Enterprises, Deepak Chopra and Simon are sometimes
referred to collectively as “CCS.” The Parties to this Agreement are sometimes
referred to collectively herein as the “Parties” or separately with NAI alone,
and CCS collectively referred to as a “Party.”

 

RECITALS

 

A. The Parties agree to modify their ongoing business relationship as initially
established by an Exclusive License Agreement and an Exclusive Manufacturing
Agreement between the Parties both entered into effective February 5, 2003.

 

B. In order to reduce their modified agreements to writing, the Parties agree to
amend and restate the February 5, 2003, Exclusive License Agreement as set forth
herein, and to cause it to remain effective as of February 5, 2003. The Parties
agree the Exclusive Manufacturing Agreement entered into between them effective
February 5, 2003, shall remain in full force and effect.

 

C. Chopra Enterprises, Deepak Chopra and Simon have developed well-known
international identities, reputations and goodwill in part through programs,
products, and services for the integration of mind, body, spirit and environment
in health care, education, business and personal development. Chopra
Enterprises, Deepak Chopra and Simon each hold the exclusive right to utilize
their respective name and/or likeness in connection with the sale, promotion and
advertising of the Products (as hereafter defined).

 

D. The operations of Chopra Enterprises rely heavily on the training, knowledge,
experience, personality, persona, image and likeness of Deepak Chopra and Simon.

 

E. Chopra Enterprises desires to expand its operations by offering Products
through its existing medical center, programs, workshops, seminars, Web site,
books, CDs and audiotapes.

 

F. NAI is in the business of designing, researching, formulating, developing,
manufacturing, packaging, distributing and marketing nutritional products. NAI
desires to design, develop, research, formulate, manufacture, and package a line
of Products for Chopra Enterprises, Deepak Chopra and Simon.

 

G. CCS desires to utilize the expertise of NAI to design, research, formulate,
develop, manufacture and package Products for CCS to market and distribute.

 

1

--------------------------------------------------------------------------------

H. NAI desires to have the exclusive rights to market, distribute and otherwise
promote and sell the line of Products manufactured by NAI for CCS through
Exclusive Channels of Distribution (as hereinafter defined).

 

I. In connection with NAI’s separate marketing and distribution of Products for
CCS, the Parties have executed an Exclusive Manufacturing Agreement of even date
herewith, granting to NAI the right to manufacture Products for CCS using the
names, likenesses, styles, persona, patents, trademarks, logos, domain names and
copyrights developed and to be developed as part of the individual, corporate
and public identities of Chopra Enterprises, Deepak Chopra and Simon.

 

J. To allow NAI the right to manufacture, market and distribute a line of
Products, Chopra Enterprises, Deepak Chopra and Simon intend to grant NAI an
exclusive license to certain proprietary rights, including but not limited to
names, likenesses, styles, persona, patents, trademarks, logos, domain names and
copyrights associated with and to become associated with Chopra Enterprises,
Deepak Chopra and Simon for NAI’s use in connection with marketing and
distributing the Products in the channels of distribution set forth in this
Agreement.

 

AGREEMENT

 

Incorporating the above recitals herein and in consideration of the covenants
and obligations contained herein and other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, the Parties agree as
follows:

 

ARTICLE I

GRANT OF LICENSE

 

1.1 Grant of License. CCS grants NAI the exclusive rights to use in connection
with distribution of the Products the names, likenesses, styles, persona,
patents, trademarks, logos, domain names, copyrights and all other attributes,
whether currently existing or to be developed in the future by Chopra
Enterprises, Deepak Chopra and Simon (collectively, the “Proprietary Assets”).
CCS grants NAI the rights to research, formulate, develop, manufacture, package
and sell the Products in the following exclusive channels of distribution:
Direct Response TV, Series TV, Direct Mail, Direct Response Radio and Direct
Response Print (“Exclusive Channels of Distribution”). NAI’s rights in the
Exclusive Channels of Distribution shall include without limitation printed
catalogs, order forms, newsletters, brochures and other bounce back or
continuity printed materials associated with the traditional repeat order
process typically included when Product orders are fulfilled. CCS grants NAI the
rights to the Proprietary Assets and Exclusive Channels of Distribution in the
following exclusive territories: United States of America, Canada and
Switzerland (“Exclusive Territory” or “Exclusive Territories”). During the term
of this Agreement, except as otherwise permitted herein, CCS will not (i) grant
to any person or entity other than NAI the right and/or license to produce, sell
and distribute Products or competitive products in the Exclusive Territory or
Exclusive Channels of Distribution or any right and/or license to use the
Proprietary Assets in connection with the advertising, publicizing, promoting,
sponsoring, endorsing, production, distribution or sale of the Products or
competitive products in the Exclusive Territory or Exclusive Channels of
Distribution; or (ii) itself or in

 

2

--------------------------------------------------------------------------------

association with any person or entity advertise, publicize, promote, sponsor,
endorse, produce, distribute or sell Products or competitive products in the
Exclusive Territory or Exclusive Channels of Distribution or use the Proprietary
Assets in connection with the advertising, publicizing, promoting, sponsoring,
endorsing production, distribution or sale of Products or competitive products
in the Exclusive Territory or Exclusive Channels of Distribution.

 

1.1.1 Exception to Exclusivity in the Direct Response Radio Channel of
Distribution. Notwithstanding the above, in connection with the marketing,
selling and distribution of the Products in the Direct Response Radio channel of
distribution, CCS shall be entitled to use the company known as HALO.TV for
syndicated broadcast radio programs, HALO.TV webcasting workshops, seminars and
other programs, and HALO.TV short form “Morning Minute” programs broadcasted via
traditional and digital medium on a subscription or sponsorship basis
(collectively “HALO.TV DRR Programming”).

 

1.1.2 Grant of Nonexclusive Rights to the Internet or World Wide Web. CCS grants
NAI the nonexclusive right to use the Internet or World Wide Web as an
additional channel of distribution in all Exclusive Territories. CCS is entitled
to market and sell all Products through HALO.TV via CCS’ associated Web site
www.halo.tv or through CCS’ independently operated Web site www.chopra.com.
(collectively, “CCS Web Sites”). CCS may enter into content, linking or similar
agreements with third parties permitting third parties to link to the CCS Web
Sites and sell Products on those third party Web sites. CCS warrants to comply
with Section 1.3.2 of this Agreement and to cooperate in good faith to permit
CCS and NAI to jointly review all third party Web sites for compliance with the
terms of this Agreement. For purposes of this Agreement, “Internet” or “World
Wide Web” or “Web” shall mean a system for accessing and viewing text, graphics,
sound and other media via the collection of computer networks known as the
Internet.

 

1.1.3 Specific Exclusions From Rights Granted to NAI. Notwithstanding the
foregoing, CCS is entitled to use the Proprietary Assets in connection with
marketing, selling and distribution of the Products in the following channels of
distribution (listed by way of example only and without limitation): Chopra
Center retail stores; KSL Property retail stores; Hampshire Resorts retail
stores; hotel, spa, hospital, medical center, health center, fitness, bookstore,
and gift retail outlets; Resort Condominiums International retail sales;
Infinite Possibilities Knowledge instructors and distributors; and sales by
Creating Wellness Centers licensed franchisees and operators. In addition, CCS
shall be entitled to send out direct mailings and solicitations to past, current
and prospective customers, patients and contacts of the Chopra Center.

 

1.2 Exclusive Territory or Exclusive Territories. Exclusive Territory or
Exclusive Territories shall have the meanings defined above in this Article.

 

1.2.1 First Right to Additional Territories. At any time during the term of this
Agreement and to the extent not prohibited by applicable law or any applicable
agreement to the contrary, CCS grants to NAI a first right to develop additional
exclusive territories to market and sell Products in NAI’s Exclusive Channels of
Distribution and nonexclusive channels of distribution on terms mutually
acceptable to the Parties.

 

3

--------------------------------------------------------------------------------

1.3 Products. “Product” or “Products” means all nutritional foods, nutritional
and dietary supplements and related materials or products of any description,
including but not limited to capsules, tablets, powders, liquids, bars, creams,
lotions, gels and other forms and packaged in any and all manners using the
names, likenesses, styles, persona, patents, trademarks, logos, domain names,
copyrights and all other attributes, whether currently existing or to be
developed in the future as part of the individual, corporate and public
identities of Chopra Enterprises, Deepak Chopra and Simon. The definition of
Product(s) includes any modification, derivative, alteration, improvement,
enhancement or successor thereof approved by the Parties. NAI shall have the
right to have the labeling and all promotional materials for all Products
include a representation that the Product has been manufactured by NAI.

 

1.3.1 First Right of Manufacture. It is the intent of NAI and CCS to develop
numerous Products for marketing and sale under this Agreement. At any time
during the term of this Agreement and to the extent not prohibited by applicable
law or any applicable agreement to the contrary, CCS grants to NAI a first right
to research, formulate, develop, manufacture, package and sell all new Products
developed in the future by the Parties. All new Products shall include any
modification, derivative, alteration, improvement, enhancement or successor of
an existing Product.

 

1.3.2 Suggested Retail Pricing. Manufacturer’s suggested retail prices shall be
set for all Products, including without limitation discount, promotion, rebate
or other price breaks. The Parties agree to communicate manufacturer’s suggested
retail prices to all third party retailers or resellers who shall have the
choice to adhere to the manufacturer’s suggested retail prices or to not sell
Products.

 

1.4 Duties of NAI. In connection with this License Agreement and the rights
granted hereunder, NAI shall:

 

1.4.1 Take such actions as are commercially reasonable in an effort to design,
develop, formulate, manufacture, promote, market, distribute and sell the
maximum number of Products while maintaining the quality of the Products and
NAI’s service to its customers. NAI agrees it and its agents shall make
aggregate testing commitments of $500,000 investment in Advertising & Promotion,
$125,000 investment in COGS, and $50,000 investment in R&D product formulation
in support of initial product development and marketing. The aggregate testing
commitments shall apply to the first eighteen months of this Agreement only and
NAI agrees to satisfy these commitments by December 31, 2004. Notwithstanding
the above, NAI is not obligated to satisfy the aggregate testing expenditure
commitments set forth in this Section if it achieves Minimum Annual Net Sales of
$1,500,000 by December 31, 2004.

 

1.4.2 Meet, confer and cooperate with CCS in connection with development of any
packaging and promotional materials utilizing the Proprietary Assets.

 

1.4.3 Cooperate with CCS with respect to its preparation of material for
inclusion in or use in connection with the existing medical center, programs,
workshops, seminars, Web site, books, CDs and audiotapes of CCS.

 

4

--------------------------------------------------------------------------------

1.4.4 Maintain a regular schedule of contact with CCS to discuss ideas,
priorities, action steps and issues.

 

1.4.5 Cooperate with the other parties in the current and future development of
the Products and use reasonable best efforts to commence production and
distribution of the initial Products as soon as reasonably practical following
the date of this Agreement.

 

1.4.6 Submit promotional copy, artwork and layout to CCS for review, comment,
and editing in accordance with the provisions of Section 1.5.3. below, so that
promotional materials reflect the public image of Chopra Enterprises, Deepak
Chopra and Simon and their activities associated with maintaining and restoring
health.

 

1.4.7 Not knowingly permit, do or commit any act or thing that would degrade,
tarnish or deprecate or disparage itself, the Products or Chopra Enterprises,
Deepak Chopra or Simon or the public image of Chopra Enterprises, Deepak Chopra
or Simon, in society or standing in the community and that it will terminate
such activities promptly upon notice.

 

1.5 Duties of CCS. In connection with this License Agreement and the rights
granted hereunder, Chopra Enterprises, Deepak Chopra and Simon shall:

 

1.5.1 Devote such time, effort, attention and energies as commercially
reasonable to create print, videotape and audiotape materials connected to the
development of custom produced Direct Response TV, Series TV, Direct Mail,
Direct Response Radio and Direct Response Print programs and be responsible for
participating in ongoing advertising and marketing efforts relating to the
Products, provided, however, such efforts do not include infomercials .

 

1.5.1.1 Use reasonable best efforts to promote and develop the Proprietary
Assets and educate the general public about the benefits of using the Products
through active writing, speaking and teaching about such benefits. In connection
with such educational and promotional efforts, Deepak Chopra and Simon shall
maintain their medical licenses and use reasonable best efforts to maintain or
expand the scope of distribution and public awareness of the existing medical
center, programs, workshops, seminars, Web site, books, CDs and audiotapes of
CCS.

 

1.5.2 Regularly meet, confer and cooperate with NAI in connection with the
development of Products and new Products.

 

1.5.3 Review and edit, prior to the expiration of ten (10) business days
following receipt of such materials, all promotional copy, artwork and layout so
that promotional materials reflect the public image of Chopra Enterprises,
Deepak Chopra and Simon and their activities associated with maintaining and
restoring health. Any failure to approve or disapprove of such materials within
the time period provided shall constitute approval.

 

1.5.4 Maintain a regular schedule of contact with NAI to discuss ideas,
priorities, action steps and issues.

 

5

--------------------------------------------------------------------------------

1.5.5 Make available to NAI a monthly business schedule and public and media
appearance schedules for Deepak Chopra’s and Simon’s educational activities
associated with maintaining and restoring health.

 

1.5.6 Not knowingly permit, do or commit any act or thing that would degrade,
tarnish, deprecate or disparage Chopra Enterprises, Deepak Chopra and Simon, the
Products or NAI or the public image of NAI in society or standing in the
community and that Chopra Enterprises, Deepak Chopra and Simon will terminate
such activities promptly upon notice.

 

1.5.7 To protect brand image, use reasonable best efforts to ensure attributes
of strong customer service are followed at all times by its affiliates and
agents in marketing, pricing, order fulfillment and distribution of all Products
in any channel of distribution.

 

1.5.8 Refrain, unless otherwise in accordance with the terms of this Agreement,
from promoting, marketing or selling any competing products such as nutritional
foods, nutritional and dietary supplements and related materials or products of
any description, including but not limited to capsules, tablets, powders,
liquids, bars and other forms and packaged in any and all manners manufactured
or distributed by anyone.

 

1.5.9 Cooperate to make Deepak Chopra and Simon available to NAI for three full
(3) business days each calendar year for exclusive business meetings or product
development meetings with NAI. Deepak Chopra and Simon shall mutually develop
and approve a per diem expense budget of One Hundred Fifty Dollars ($150) per
day plus reimbursement to Deepak Chopra and Simon each for travel related
expenses and other approved costs incurred exclusively on behalf of NAI. Travel
related expenses eligible for reimbursement include without limitation first
class airfare, car and driver and hotel accommodations. NAI shall approve and
reimburse Deepak Chopra and Simon for travel related expenses incurred in
connection with their promotion of the Products on a non-exclusive basis in
amounts mutually agreed upon by the Parties.

 

ARTICLE II

ROYALTIES

 

2.1 Royalties. NAI shall pay Chopra Enterprises a royalty on the annual Net
Sales revenue from the Products. “Net Sales” shall be computed as the gross
invoice amount billed by NAI to purchasers of the Products, less customer
shipping and handling charges, credit card charge fees and returns actually
credited. The amount of such royalty shall be the amount set forth in Section
2.1.2 below:

 

2.1.1 Minimum Annual Net Sales. During the periods of the term of this Agreement
set forth below, NAI shall produce the following “Minimum Annual Net Sales.”

 

July 1, 2003 through December 31, 2004

   $ 1,500,000

January 1, 2005 through December 31, 2005

   $ 3,000,000

January 1, 2006 through December 31, 2006

   $ 6,000,000

January 1, 2007 through December 31, 2007

   $ 12,000,000

 

6

--------------------------------------------------------------------------------

January 1, 2008 through December 31, 2008

   $ 14,400,000

January 1, 2009 through December 31, 2009

   $ 17,280,000

January 1, 2010 through December 31, 2010

   $ 20,736,000

January 1, 2011 through December 31, 2011

   $ 22,809,600

January 1, 2012 through December 31, 2012

   $ 25,090,560

January 1, 2013 through December 31, 2013

   $ 27,599,616

 

In the event the Minimum Annual Net Sales are not achieved, NAI shall have the
option to retain all rights under this Agreement by paying to Chopra Enterprises
the difference between the royalties actually paid to Chopra Enterprises
pursuant to Section 2.1.2 for Net Sales achieved during the respective year, and
the royalties that would have been due if the Minimum Annual Net Sales
requirement had been achieved. If the Minimum Annual Net Sales requirement is
not achieved and NAI does not pay to Chopra Enterprises such difference, Chopra
Enterprises shall have the right in its sole discretion to: (i) waive the
non-compliance; or (ii) notify NAI this License Agreement has been automatically
converted to a non-exclusive license on otherwise all the same terms and
conditions; or (iii) terminate this License Agreement at which time all rights
previously licensed shall revert to Chopra Enterprises, Deepak Chopra and Simon.
In addition, if the Minimum Annual Net Sales requirement is not achieved and NAI
does not pay to Chopra Enterprises such difference, and Chopra Enterprises
elects to terminate this License Agreement, Chopra Enterprises shall have the
right in its sole discretion to elect to terminate the Exclusive Manufacturing
Agreement entered into of even date herewith. No waiver of this requirement by
CCS (if any) shall act as a future waiver.

 

2.1.2 Annual Net Sale Royalty. During the entire term of this Agreement, the
royalty due for the period shall be in the amount set forth in this Section
2.1.2.

 

10% of annual Net Sales not exceeding $25,000,000;

11% of annual Net Sales in excess of $25,000,000 but not exceeding $30,000,000;

12% of annual Net Sales in excess of $30,000,000 but not exceeding $35,000,000;

13% of annual Net Sales in excess of $35,000,000 but not exceeding $40,000,000;

14% of annual Net Sales in excess of $40,000,000 but not exceeding $45,000,000;

15% of annual Net Sales in excess of $45,000,000.

 

2.1.3 Royalty Payments. Royalty payments shall be made quarterly on or before
the 30th day of the month succeeding the close of each calendar quarter except
that in calendar year 2004 only, minimum royalty payments shall be made on the
first day of each calendar quarter in accordance with the following payment
schedule:

 

Q1 2004 - $30,000 royalty due January 1, 2004

Q2 2004 - $35,000 royalty due April 1, 2004

Q3 2004 - $40,000 royalty due July 1, 2004

Q4 2004 - $45,000 royalty due October 1, 2004

 

2.1.3.1 Each royalty payment shall be supplemented by a report setting forth the
information described in Section 2.2. All payments shall be made in United
States

 

7

--------------------------------------------------------------------------------

currency and be drawn on a United States bank. The amount of the royalty payment
due for each of the first three (3) quarters of each annual period described in
Section 2.1.1, shall be calculated according to Section 2.1.2. Other than for
calendar year 2004, as set forth above, the amount of the royalty payment due
for the fourth quarter of each annual period described in Section 2.1.1, shall
be the greater of: (i) the amount calculated for the quarter pursuant to Section
2.1.2; or (ii) the minimum amount due for the annual period as set forth in
Section 2.1.1 less the amount of all royalties already paid for the same annual
period.

 

2.1.3.2 Notwithstanding the above, with respect to each minimum quarterly
royalty payment due in 2004, as set forth in Section 2.1.3 above, if the actual
royalty due on Net Sales of Products in each quarter of 2004 is greater than the
minimum quarterly royalty payment, then NAI shall: (i) pay the difference
between the greater Net Sales royalty due and the minimum quarterly royalty
payment; (ii) receive credit for the difference paid, and (iii) apply that
credit to reduce the next minimum quarterly royalty payment due.

 

2.1.4 Minimum Guaranteed Royalty for Period Ending December 31, 2004. For the
period ending December 31, 2004, NAI shall pay a minimum royalty totaling
$150,000 to CCS, or the difference between the royalties actually paid to Chopra
Enterprises pursuant to Section 2.1.2 for Net Sales achieved during the initial
year ending December 31, 2004, and $150,000, if any. The minimum guaranteed
royalty shall apply only to the period ending December 31, 2004, and shall apply
in the event NAI elects to terminate this Agreement effective on or before
December 31, 2004. Notwithstanding the preceding, NAI is not obligated to pay
the minimum guaranteed royalty set forth in this Section if it satisfies the
aggregate testing expenditure commitments set forth in Section 1.4.1 prior to
December 31, 2004. Notwithstanding the preceding, in the event NAI satisfies the
aggregate testing expenditure commitments set forth in Section 1.4.1 prior to
December 31, 2004, and NAI elects to terminate this Agreement on or before
December 31, 2004, then CCS shall reimburse NAI for the difference between
royalties actually paid to Chopra Enterprises pursuant to Section 2.1.3 and
royalties payable to Chopra Enterprises pursuant to Section 2.1.2 for Net Sales
achieved during the initial year ending on the termination date.

 

2.1.5 Net Sales Not Subject to Royalty. NAI is not required to pay a royalty for
any Product purchased by or fulfilled for CCS or its agents or selling partners
pursuant to this Agreement.

 

2.2 Reports. NAI shall deliver a report to CCS within thirty (30) days after the
end of each calendar quarter which shall consist of an accurate statement of Net
Sales of Products along with any royalty payments or sublicensing revenues due
to CCS. Such reports shall be provided to CCS regardless of whether any Products
were sold during the period covered by the report. The acceptance by CCS of any
of the statements furnished or royalties paid shall not preclude CCS questioning
the correctness at any time of any payments or statements. In connection
therewith, CCS shall be entitled to examine or audit at its own expense the
documents underlying the statements described in this Section not more often
than annually. In the event such audit reveals an understatement of royalties
due hereunder in an amount equal to or exceeding 5% of the actual royalties due
over the period of such audit, NAI shall bear the cost of audit. Any such
underpayment shall be immediately due and payable, with interest accrued

 

8

--------------------------------------------------------------------------------

from the date the payment was originally due at the lesser of 1.5% per month or
the maximum rate permitted by law.

 

ARTICLE III

TERM OF AGREEMENT

 

3.1 Effective Date. The term “Effective Date” shall mean, and this Agreement is
effective as, of the date first written above.

 

3.2 Term and Termination.

 

3.2.1 Initial Term. This Agreement shall remain in effect for a period of ten
(10) years from the date hereof unless earlier terminated in accordance
herewith. Upon expiration of the initial term, the term of this Agreement shall
be automatically extended for successive one (1) year periods unless terminated
by either Party by written notice delivered at least 120 days prior to
expiration of any such period.

 

3.2.2 Right to Terminate by NAI. NAI may terminate this Agreement at any time
upon giving CCS ninety (90) days notice, provided, however, if NAI terminates
this Agreement on or before December 31, 2004, NAI shall make the minimum
royalty due, if any, pursuant to Section 2.1.4.

 

3.3 Right to Terminate by CCS. CCS shall have the right to terminate this
Agreement if:

 

3.3.1 After notice from CCS, NAI materially fails to comply with any covenant in
this Agreement and such failure continues for more than thirty (30) days
following receipt of written notice unless such failure cannot reasonably be
cured within 30 days then only if NAI fails to commence such cure within thirty
(30) days and diligently thereafter prosecutes such cure to completion within 90
days or other commercially reasonable time period.

 

3.3.2 NAI assigns its rights to a party who is at the time of transfer involved
as an adverse party in material and adverse litigation against CCS.

 

3.3.3 NAI fails to make the royalty payments as required by Article II within
thirty (30) days following receipt of written notice from CCS of the late
payment.

 

3.4 Termination on Specific Events. Either Party may terminate this Agreement
immediately only if:

 

3.4.1 The other Party suspends or discontinues its business operations, makes
any assignment for the benefit of its creditors, commences voluntary proceedings
for liquidation in bankruptcy, admits in writing its inability to pay its debts
generally as they become due or consents to the appointment of a receiver,
trustee or liquidator of the other Party or of all or any material part of its
property, or if there is an execution of a material portion of its assets.

 

9

--------------------------------------------------------------------------------

3.4.2 The other Party shall commence any case, proceeding or other action under
any existing or future law of any jurisdiction, domestic or foreign, relating to
bankruptcy, insolvency, reorganization or relief of debtors seeking to have an
order for relief entered with respect to it, or seeking to adjudicate it a
bankrupt or insolvent, or seeking reorganization, arrangement, adjustment,
winding-up, liquidation, dissolution, composition or other relief with respect
to it or its debts.

 

3.4.3 (A) There shall be commenced against the other Party any case, proceeding
or other action of a nature referred to in Section 3.4.2 above which results in
the entry of an order for relief or any such adjudication or appointment or
remains undismissed, undischarged, unstayed or unbonded for period of ninety
(90) days; or (B) there shall be commenced against the other Party any case,
proceeding or other action seeking issuance of a warrant of attachment,
execution, distraint or similar process against all or any substantial part of
its assets, which results in the entry of an order for any such relief which
shall not have been vacated, discharged or stayed or bonded pending appeal
within ninety (90) days from the entry thereof; or (C) the other Party shall
take any action in furtherance of, or indicating its consent to, approval of, or
acquiescence in, any of the acts set forth in clause (A) or (B) above.

 

3.4.4 A Party acts in a manner deemed by the other Party to be in breach of
either Section 1.4.7 or Section 1.5.6 of this Agreement whereupon the other
Party shall have the right to give written notice of termination of this
Agreement, providing complete information regarding the claimed breach and
providing a period of ten (10) calendar days in which to either completely
correct the conduct deemed in violation of either Section 1.4.7 or Section 1.5.6
to the reasonable satisfaction of the Party giving notice, or prove to the
reasonable satisfaction of the Party giving notice that no violation occurred.

 

3.5 Duties on Termination. Upon termination of this Agreement, copies of all
records related to CCS shall be kept by NAI for a minimum of three (3) years
following production. In addition, NAI shall take all acts reasonably necessary
to maintain the Proprietary Assets and deliver to CCS all materials strictly
related thereto. The Parties shall cooperate and utilize their reasonable best
efforts to prepare such final reconciliations of accounts and amounts to be
provided as between them in connection with such termination.

 

3.6 Reversion of Rights. Upon the expiration of the term of this Agreement or
earlier termination of this Agreement for any of the reasons set forth herein,
all rights, licenses, and privileges granted to NAI hereunder shall
automatically cease and revert to CCS, and NAI shall execute any and all
documents evidencing such automatic reversion.

 

ARTICLE IV

MAINTENANCE OF INTELLECTUAL PROPERTY

 

4.1 Protection of Proprietary Assets. CCS shall seek in its own name or the name
of any individual or entity bound by the terms of this Agreement and at its own
expense, all appropriate patent, trademark, copyright or other available means
of intellectual property protection for the Proprietary Assets. In the event CCS
does not seek any appropriate patent, trademarks, copyright or other available
means of intellectual property protection within thirty

 

10

--------------------------------------------------------------------------------

(30) days following a written request by NAI, NAI may seek such protection on
behalf of CCS and itself and credit the cost of such action against royalties
due or becoming due under the terms of Article II.

 

4.2 Protection of Proprietary Components. NAI may seek in its own name and at
its own expense, and if obtained, shall maintain appropriate patent, trademark,
copyright or registration protection and ownership for any element or component
proprietary to NAI that is included in the Products or any part thereof.

 

4.3 Ownership of Formulas, Specifications and Technical Information. All
Formulas, Specifications and Technical Information, as defined in the Exclusive
Manufacturing Agreement of even date herewith, developed by either Party for all
Products shall remain the property of that Party during and following the term
of this Agreement.

 

4.4 Enforcement of Intellectual Property Rights.

 

4.4.1 In the event any Party becomes aware of any claim or unauthorized use, or
infringement on the Proprietary Assets or Products during the term of this
Agreement, that Party shall immediately notify all of the other Parties of such
violation and shall consult with and cooperate in any way requested by any Party
with respect to the enforcement of all intellectual property rights.

 

4.4.2 CCS shall, at its own cost and expense, take all action necessary to
enforce its rights and cause any violation with respect to Proprietary Assets to
cease and be remedied. In the event CCS fails to take all action necessary to
remedy any such violation, NAI, upon ten (10) business days prior written
notice, may take such action and may offset one half the costs incurred in
connection with such actions against any amounts coming due to CCS under the
terms of Article II. CCS shall approve or disapprove such action within ten (10)
business days following receipt of notice as provided above and approval may not
be unreasonably withheld. In connection with such action, the Parties shall
execute all papers necessary or appropriate in the discretion of the Party
taking such action in response to a violation or infringement of the Proprietary
Assets, and shall testify in any legal action whenever requested to do so by the
prosecuting Party.

 

4.5 Assistance in Protection. In addition to their respective undertakings set
forth in the preceding Sections, the Parties agree to render to each other all
assistance reasonably requested of them in connection with the protection of the
Proprietary Assets and to make promptly available to one another information
they possess or to which they have access that may be of use to the other in
such protection.

 

4.6 Notice of Infringement. In the event any Party becomes aware of any claim or
unauthorized use with respect to the Proprietary Assets, it will notify the
other Parties of such claim or unauthorized use immediately but in no event more
than two (2) business days following the date on which it became aware of the
claim or unauthorized use.

 

11

--------------------------------------------------------------------------------

4.7 Preservation of Proprietary Assets. Chopra Enterprises, Deepak Chopra and
Simon undertake and agree to maintain the existing image and public persona of
themselves, and will use reasonable best efforts to further develop, improve and
otherwise enhance the image and public persona of themselves. In no event will
Chopra Enterprises, Deepak Chopra and Simon take any action inconsistent with
the public image of Chopra Enterprises, Deepak Chopra and Simon or denigrate any
of the Products or the Proprietary Assets or in any way reflect negatively on
the Products or the Proprietary Assets.

 

4.8 Regulatory Action. If the Food and Drug Administration or any other federal,
state or local government agency gives notice of or makes an inspection at any
Party’s premises, seizes any Product or requests a recall, the other Parties
shall be notified immediately but in no event later than the next business day.
Duplicates of any samples of Product taken by such agency shall be sent to the
other Parties promptly. In the event of any action described in this Section,
the Parties shall cooperate in determining the response, if any, to be made to
such action and each Party agrees NAI shall be the Parties’ representative in
responding to such action, and each agrees to cooperate with and assist NAI in
attempting to resolve any such action and to refrain from any activity with
respect to such action which is not previously approved by NAI, except such
activities as may be required by law.

 

4.9 NAI Customer List. NAI may maintain a list of its customers purchasing from
NAI. This information is NAI’s exclusive property.

 

4.10 Fulfillment and Call Center Vendors. The Parties understand and approve of
NAI’s use of third party fulfillment and call center vendors to assist in its
distribution of the Products, and acknowledge and approve of such arrangements.
NAI agrees any third party fulfillment and call center vendor must be capable of
providing telephone customer service that appropriately reflects the public
image of Chopra Enterprises, Deepak Chopra and Simon.

 

ARTICLE V

REPRESENTATIONS AND WARRANTIES

 

5.1 Representations and Warranties of Chopra Enterprises, Deepak Chopra and
Simon. Chopra Enterprises, Deepak Chopra and Simon own and/or control the
exclusive rights to the Proprietary Assets, and have the authority to grant this
license to use the Proprietary Assets in the manner and form provided in this
Agreement. Neither Chopra Enterprises, Deepak Chopra nor Simon have received
notice of any claim with respect to any of the Proprietary Assets which is
inconsistent with exclusive ownership of the Proprietary Assets, nor have any of
them received any notice of any unauthorized use thereof. The Proprietary Assets
do not infringe upon or violate any rights of any third party. Neither the
execution and delivery of this Agreement nor the consummation of the
transactions contemplated hereunder will violate or constitute a default under
any agreement or instrument to which Chopra Enterprises, Deepak Chopra or Simon
is a Party or by which any of them is bound.

 

5.1.1 Competitive Protection. Effective as of the date of this Agreement and
continuing throughout the term, Chopra Enterprises, Deepak Chopra and Simon each
agree to not render services in the form of advertising, publicizing, promoting,
sponsoring or endorsing any

 

12

--------------------------------------------------------------------------------

items, products or services that compete in the marketplace with any Products or
services contemplated by this Agreement. Additionally, Chopra Enterprises,
Deepak Chopra or Simon will neither permit nor authorize the use of any
Proprietary Assets, including without limitation, the name and/or likeness
(photograph and/or drawing), voice, signature and/or endorsement of any of them
by any Direct Competitor or by any third party whose items, products or services
compete in the marketplace with any Products or services contemplated by this
Agreement except as may be used for the non-profit, non-commercial activities of
Chopra Enterprises, provided such activities are not related in any way to the
promotion of items, products or services of any Direct Competitor or any third
party whose items, products or services compete in the marketplace with any
Products or services contemplated by this Agreement. For purposes of this
Agreement, “Direct Competitor” shall refer to any business entity that develops
items and/or sells products or provides services relating to the design,
development, research, formulation, manufacture and packaging of nutritional
products or other Products contemplated by this Agreement.

 

5.1.2 Without limiting the generality of the foregoing, Chopra Enterprises,
Deepak Chopra and Simon shall not directly or indirectly participate in the
development, production or promotion by any Direct Competitor or any third party
of any items, products or services that compete in the marketplace with any
Products or services contemplated by this Agreement.

 

5.2 Representations and Warranties of NAI. NAI has the authority to enter into
this Agreement. Neither the execution and delivery of this Agreement nor the
consummation of the transactions contemplated hereunder will violate or
constitute a default under any agreement or instrument to which NAI is a party
or by which it is bound. NAI shall be the sole owner of all preexisting Product
formulations, packaging, designs and other intellectual property associated with
the Products or any element or component proprietary to NAI that is included in
the Products or any part thereof and none of the actions contemplated by this
Agreement will violate or constitute a default under any agreement or instrument
to which NAI is a party or by which it is bound.

 

ARTICLE VI

CONFIDENTIALITY

 

6.1 Duty to Protect Confidential Information. Any confidential information
disclosed or conveyed by either Party to the other in connection with its
business by written communication and marked as confidential, or by oral
communication and confirmed in writing within thirty (30) working days of oral
disclosure, shall be treated by the receiving Party as secret and confidential
and shall be held in trust for the disclosing Party. The receiving Party shall
treat such information and take such steps to assure its continued
confidentiality in like manner as it would use to protect its own trade secrets
or confidential information and will not, except as required by law, disclose
any such confidential information received from the other Party to any third
Party who is not bound under a confidentiality and non-disclosure agreement.

 

6.2 Means of Protecting Confidential Information. NAI and CCS agree to take
reasonable steps to ensure the proprietary and confidential nature of the
other’s confidential

 

13

--------------------------------------------------------------------------------

information and the Proprietary Assets and Product(s) in which confidential
information is embodied or included and to protect the same from loss or theft
and agree to clearly mark such confidential information and properly indicate
its proprietary nature.

 

6.3 Terms of Agreement. Except as otherwise required by law including, but not
limited to, NAI’s disclosure obligations in connection with the U.S. Securities
Act of 1934, the Parties agree that the terms of this Agreement are proprietary
and confidential, as is the existence of this Agreement. Each Party agrees to
maintain the existence of this Agreement and the terms and information contained
herein strictly confidential and will not disclose any such information to any
person who is not a Party hereto without the prior written consent of all
Parties, which consent may be granted or withheld in the absolute discretion of
each Party.

 

6.4 CCS Use of NAI Confidential Information. The Parties acknowledge CCS is
interested, for the purpose of enlisting participants in CCS activities, in
utilizing confidential information developed by NAI in connection with NAI’s
distribution of Products. The Parties agree that upon the request of CCS they
will meet, confer and negotiate in good faith the terms under which CCS may use
such information to enlist additional CCS participants while providing adequate
protections for the reasonable confidentiality and privacy interests of NAI and
its customers in connection therewith.

 

6.5 Provisions Divisible. It is agreed by all Parties that the foregoing
covenants are appropriate and reasonable in light of the nature and extent of
the business conducted by the Parties and their respective relationships. It is
further agreed that the covenants set forth herein are divisible in the event
they are held to be invalid, unreasonable, arbitrary or against public policy.
Further, it is agreed by the Parties that if any court of competent jurisdiction
or authorized arbitrator makes such a determination, they may determine what
time period and geographical area are reasonably necessary to protect the
Parties’ legitimate business interests and which are enforceable.

 

6.6 Irreparable Injury. Each Party acknowledges that damages at law will be an
insufficient remedy for violation of the terms of this Article and that the
other Party would suffer irreparable injury as a result of such violation.
Accordingly, it is agreed upon application to a court of competent jurisdiction,
the Parties may obtain injunctive relief to enforce the provisions of this
Article of this Agreement, which injunctive relief shall be in addition to any
other rights or remedies available to it or them.

 

6.7 Extended Term of Confidentiality. It is recognized by all Parties that due
to their respective positions of confidence giving rise to access to
confidential, proprietary information during the term of this Agreement, that
the provisions of this Article VI apply during the term of this Agreement and
for a period of three (3) years thereafter.

 

ARTICLE VII

CLAIMS AND INDEMNIFICATION

 

7.1 Indemnification by NAI Against Third-Party Claims. Except as otherwise set
forth above in Article VI, NAI shall indemnify, defend, and hold harmless CCS,
its subsidiaries,

 

14

--------------------------------------------------------------------------------

affiliated and/or controlled companies and all sublicensees, as well as their
respective officers, directors, agents, and employees, from and against any and
all damage, loss, expense (including reasonable attorneys’ fees and costs),
award, settlement, or other obligation arising out of any claims, demands,
actions, suits, or prosecutions that may be made or instituted against them or
any of them, (a) arising from any alleged breach of NAI’s warranties contained
herein, and (b) any claims arising out of NAI’s marketing, distribution,
promotion, sale, or use of Products or Proprietary Assets, including any claims
arising out of Section 1.3.2.

 

7.2 Indemnification by CCS Against Third-Party Claims. Except as otherwise set
forth above in Article VI, Chopra Enterprises, Deepak Chopra or Simon shall,
jointly and severally, indemnify, defend, and hold harmless NAI, its
subsidiaries, affiliated and/or controlled companies and all sublicensees, as
well as their respective officers, directors, agents, and employees, from and
against any and all damage, loss, expense (including reasonable attorneys’ fees
and costs), award, settlement, or other obligation arising out of any claims,
demands, actions, suits, or prosecutions that may be made or instituted against
them or any of them, (a) arising from any alleged breach of CCS’ warranties
contained herein, (b) arising from any injury or death from any defect in the
Proprietary Assets specifically excluding any claim relating to the Products
manufactured by NAI exclusive of the Proprietary Assets; and (c) any claims
arising out of the content or manner of CCS’ marketing, distribution, promotion,
sale, or recommended use of Products or Proprietary Assets.

 

7.3 Insurance. NAI shall carry with companies reasonably satisfactory to CCS:
(i) Workers’ Compensation and Employees’ Liability Insurance; (ii) Standard Form
Fire and Extended Coverage Insurance for the full replacement value of any of
the Products or any premiums or packaging materials; and (iii) Public Liability
Insurance including Contractual Liability and Products Liability Coverage with a
combined single limit of not less than Five Million Dollars ($5,000,000). NAI
shall submit policies and/or certificates of insurance evidencing the above
coverage upon CCS’ written request. NAI shall name CCS as additional insureds
under such policies. Product Liability Insurance shall be maintained in effect
by NAI for a period of one (1) year from the date of the last delivery of any
Product by NAI to CCS. In case of NAI’s failure to carry said policies and/or
furnish certificates of insurance or upon cancellation of any required
insurance, CCS may, at its option, immediately terminate this Agreement unless
NAI has obtained substitute insurance coverage before such insurance becomes
canceled and provides CCS with satisfactory evidence thereof.

 

7.4 No Consequential Damages. EXCEPT FOR THE CIRCUMSTANCES SET FORTH IN SECTION
1.4.7, UNDER NO CIRCUMSTANCES SHALL NAI OR ANY AFFILIATE OF NAI HAVE ANY
LIABILITY WHATSOEVER FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES, such as, but not
limited to, loss of profit or revenue; loss of use of the Products; cost of
capital; or claims resulting from contracts between CCS, their customers and/or
suppliers. Unless expressly provided for herein, in no event shall NAI or any
affiliate of NAI assume responsibility or liability for (i) penalties, penalty,
clauses or liquidated damages clauses of any description, or (ii)
indemnification of CCS or others for costs, damages or expenses arising out of
or related to the Products or part thereof.

 

15

--------------------------------------------------------------------------------

ARTICLE VIII

MISCELLANEOUS PROVISIONS

 

8.1 Sublicense. NAI may sublicense the rights granted pursuant to this
Agreement, provided NAI obtains CCS’ prior written consent to such sublicense.
CCS’ consent to any sublicense shall not be unreasonably withheld and in any
such sublicense agreement, provision shall be made so that CCS receives such
revenue or royalty payment as provided for herein. Any sublicense granted in
violation of this provision shall be void.

 

8.2 Entire Agreement; Amendment. This Agreement contains the entire
understanding between the Parties with respect to the subject matter hereof and
supersedes all prior or contemporaneous written or oral negotiations and
agreements between them regarding the subject matter hereof. Only a writing
signed by all Parties or by duly authorized corporate officers of a Party and
clearly designated as an amendment to this Agreement by an appropriate heading
may amend this Agreement.

 

8.3 Severability. If any provision or portion thereof of this Agreement is
determined to be invalid or unenforceable, the provision or portion shall be
deemed to be severable from the remainder of this Agreement and shall not cause
the invalidity or unenforceability of the remainder of this Agreement.

 

8.4 No Implied Waivers. The failure of either Party at any time to require
performance by the other Party of any provision hereof shall not affect in any
way the right to require such performance at any later time, nor shall the
waiver by either Party of a breach of any provision hereof be taken or held to
be a waiver of such provision.

 

8.5 Attorneys Fees. If any arbitration or legal proceeding is brought for the
enforcement of this Agreement, or because of an alleged breach, default or
misrepresentation in connection with any provision of this Agreement or other
dispute concerning this Agreement, the successful or prevailing Party shall be
entitled to recover reasonable attorneys fees incurred in connection with such
arbitration or legal proceeding. The term “Prevailing Party” shall mean the
Party that is entitled to recover its costs in the proceeding under applicable
law, or the Party designated as such by the court or the arbitrators.

 

8.6 Arbitration. Any dispute, controversy or claim arising from, out of or in
connection with, or relating to, this Agreement or any breach or alleged breach
of this Agreement, except allegations of violations of Federal or State
securities laws, will upon the request of any Party involved be submitted to any
private arbitration service utilizing former judges as mediators and approved by
the Parties. The dispute once submitted shall be settled by binding arbitration
conducted in San Diego, California (or at any other place or under any other
form of arbitration mutually acceptable to Parties involved). The single
arbitrator shall follow and apply the federal rules of evidence and the
applicable local federal rules of governing discovery in the arbitration. Any
award rendered shall be final, binding and conclusive upon the Parties and shall
be non-appealable, and a judgment thereon may be entered in the highest State or
Federal court of the forum, having jurisdiction. The expenses of the arbitration
shall be borne equally by the Parties to the arbitration, provided that each
Party shall pay for and bear the cost of

 

16

--------------------------------------------------------------------------------

its own experts, evidence and attorneys’ fees, except that in the discretion of
the arbitrator, any award may include the costs, fees and expenses of a Party’s
attorneys.

 

8.7 Governing Law. This Agreement shall be construed and interpreted under the
laws of the State of California. All disputes or controversies or questions
arising under or relating to this Agreement between the Parties hereto in
relation to this Agreement shall be construed and resolved under the laws of the
State of California. Each Party acknowledges and waives any objection to venue
for such disputes in state or federal courts sitting in San Diego, California.
Any judgments upon the award entered by the arbitrator may be entered in the
State or Federal Courts situated in the State of California.

 

8.8 Counterparts. This Agreement may be executed in one or more counterparts,
each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument.

 

8.9 Captions. The captions of the sections and subsections of this Agreement are
included for reference purposes only and are not intended to be a part of the
Agreement or in any way to define, limited or describe the scope or intent of
the particular provision to which they refer.

 

8.10 Relationship of the Parties. The terms and provisions of this agreement are
intended to be a license agreement and it shall not in any respect be construed
to constitute NAI or CCS as the agent, employee, partner or joint venturer of
the other. All persons employed by any Party in connection with the manufacture,
distribution, marketing, promotion and sale of the Products shall be the
employees or agents of that Party and under no circumstances shall a Party’s
employees or agents be deemed to be employees or agents of any other Party. Each
Party will bear the cost of its distribution, marketing, promotion and sale of
Products through its own channels. In the event any Parties utilize common
vendors or contractors, each Party utilizing such common vendor or contractor
will maintain such relationship and any obligations, agreements and accounts
with such common vendor or contractor separate and distinct from any other
Party’s.

 

8.11 Notices. All notices, consents, waivers and other communications under this
Agreement must be in writing and will be deemed to have been duly given upon (a)
delivery by hand (with written confirmation of receipt), (b) one day after
confirmation of receipt if sent by facsimile, (c) one day after deposit with a
nationally recognized overnight delivery service (receipt requested), or (d)
five days after deposit in the United States mail by certified delivery, return
receipt requested. Notices shall be sent in each case to the appropriate
addresses indicated for each Party below, or to such other addresses as a Party
may designate in writing by notice to the other Party:

 

17

--------------------------------------------------------------------------------

If to NAI:   with a copy to:

Natural Alternatives International, Inc.

1185 Linda Vista Drive

San Marcos, California 92069

Attn: President or Chief Operating Officer

Telephone: (760) 736-7742

Facsimile: (760) 591-9637

 

Fisher Thurber LLP

4225 Executive Square, Suite 1600

La Jolla, California 92037

Attention: David A. Fisher

Telephone: (858) 535-9400

Facsimile: (858) 535-1616

If to Chopra Enterprises, Deepak Chopra or Simon:   with a copy to:

c/o Chopra Center for Well Being, La Costa Resort and Spa

2100 Costa Del Mar Road

La Costa CA 92009

Telephone: (760) 931-7564

Facsimile: (760) 931-7572

 

Howard Simon, Esq.

1959 Thayer Avenue

Los Angeles CA 90025

Telephone: (310) 474-6022

Facsimile: (310) 474-2428

 

8.11.1 Designated Contact. If a specific contact person is designated in a
provision, notice concerning the subject matter of such provision shall be
directed to such person. The address, facsimile number or the name of any Party
or contact person or other number may be changed by sending notice in the manner
set forth above.

 

8.12 Key Man Insurance. NAI shall have the right, but no obligation to purchase
policies of insurance on the lives of Deepak Chopra and Simon and on either not
becoming disabled. NAI shall bear the costs of any such policies and it on its
designee shall be the owner and beneficiary of such policies. Deepak Chopra and
Simon agree to cooperate with NAI in connection with the purchase of such
policies and shall take any reasonable action requested by NAI in order to
facilitate the issuance of such policies.

 

8.13 Incapacity or Death of Deepak Chopra or David Simon. Except as otherwise
provided herein, the rights granted to NAI in this Agreement are intended to
survive the incapacity or death of Deepak Chopra or Simon. Upon the occurrence
of any such event, all actions with respect to Deepak Chopra hereunder shall be
exercisable on behalf of Deepak Chopra by another person (the “Chopra
Representative”) who, at the execution date of this agreement, is hereby
designated by Deepak Chopra to be his daughter Mallika Chopra. Upon the
occurrence of any such event, all actions with respect to David Simon hereunder
shall be exercisable on behalf of David Simon by another person (the “Simon
Representative”) who, at the execution date of this agreement, is hereby
designated by David Simon to be his brother Howard Simon.

 

8.13.1 If prior to the death of Deepak Chopra or Simon, either is pronounced to
be incapacitated (i.e., as being incapable of managing or conducting his own
business affairs due to physical or mental infirmity) by his Representative,
then said Representative shall thereafter and for so long as Deepak Chopra or
Simon or both of them is incapacitated have full right to

 

18

--------------------------------------------------------------------------------

take any and all acts on behalf of Deepak Chopra or Simon under this Agreement.
Any Representative appointed in accordance with this Section shall have full
right to take any and all acts on behalf of Deepak Chopra or Simon under this
Agreement and NAI may rely on such acts as the lawful and duly authorized acts
of Deepak Chopra and Simon.

 

8.14 Successors, Assignment. This Agreement shall inure to the benefit of and be
binding upon the successors and permitted assigns of the Parties. NAI and Chopra
Enterprises may assign their rights and obligations under this Agreement to
their Affiliate. Any such assignment will not release or discharge them from any
liability or obligation hereunder. The rights and obligations or Chopra
Enterprises and NAI may only be assigned to other than Affiliate after first
obtaining the other Party’s written consent, which consent may not be
unreasonably withheld. The rights and obligations of Deepak Chopra and Simon are
personal and may not be assigned hereunder without NAI’s written consent which
may be given or withheld in NAI’s sole discretion. As used herein, Affiliate
shall refer to any person or entity that is under direct or indirect control of
the applicable Party. The term “control” includes without limitation, ownership
of interest representing a majority of the total voting power in an entity or
the ability to manage or direct such entity.

 

8.15 Further Assurances. The Parties agree (a) to furnish upon request to each
other such further information, (b) to execute and deliver to each other such
other documents, and (c) to do such other acts and things, all as the other
Party may reasonably request for the purpose of carrying out the intent of this
Agreement and the documents referred to in this Agreement.

 

[signature page follows]

 

19

--------------------------------------------------------------------------------

The Parties have executed this Exclusive License Agreement as of the day and
year first above written.

 

NATURAL ALTERNATIVES INTERNATIONAL, INC.

a Delaware corporation

By:  

/s/ Randy Weaver

   

Randell Weaver, President

 

CHOPRA ENTERPRISES, LLC

a California limited liability company

By:  

/s/ Deepak Chopra

   

Deepak Chopra, Managing Member

 

DEEPAK CHOPRA, M.D.

By:  

/s/ Deepak Chopra

   

Deepak Chopra, M.D.

 

DAVID SIMON, M.D.

By:  

/s/ David Simon

   

David Simon, M.D.

 

20